These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3414786)

  • 41. Interleukin-18 inhibits lodging and subsequent growth of human multiple myeloma cells in the bone marrow.
    Yamashita K; Iwasaki T; Tsujimura T; Sugihara A; Yamada N; Ueda H; Okamura H; Futani H; Maruo S; Terada N
    Oncol Rep; 2002; 9(6):1237-44. PubMed ID: 12375027
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of myeloma growth in mice by antigen and regulatory idiotopes.
    Rubinstein LJ; Bona CA
    Cancer Res; 1986 Apr; 46(4 Pt 1):1603-7. PubMed ID: 3948149
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Generation of monoclonal antibodies to surface proteins of human multiple myeloma employing membrane extracts for murine in vivo immunizations.
    Ravi M; Balaji S; Srinivasan L; Paul SF
    Hybridoma (Larchmt); 2009 Oct; 28(5):369-71. PubMed ID: 19857119
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Histologic studies of paraproteinemic nephropathy in BALB/c mice with mineral oil-induced plasmacytoma].
    Janz S; Rassmann B; Raabe F; Storch H
    Z Urol Nephrol; 1989 Dec; 82(12):671-8. PubMed ID: 2629422
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Disseminated growth of murine plasmacytoma: similarities to multiple myeloma.
    Roschke V; Hausner P; Kopantzev E; Pumphrey JG; Riminucci M; Hilbert DM; Rudikoff S
    Cancer Res; 1998 Feb; 58(3):535-41. PubMed ID: 9458102
    [TBL] [Abstract][Full Text] [Related]  

  • 46. BALB/c and C57Bl/6 mice infected with virulent Burkholderia pseudomallei provide contrasting animal models for the acute and chronic forms of human melioidosis.
    Leakey AK; Ulett GC; Hirst RG
    Microb Pathog; 1998 May; 24(5):269-75. PubMed ID: 9600859
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aging in the laboratory animal.
    Hollander CF
    Maturitas; 1984 Nov; 6(3):253-8. PubMed ID: 6513796
    [No Abstract]   [Full Text] [Related]  

  • 48. Cell hybridizaiton: an explanation for the phenotypic diversity of certain tumours.
    Warner TF
    Med Hypotheses; 1975; 1(1):51-7. PubMed ID: 1105094
    [No Abstract]   [Full Text] [Related]  

  • 49. A murine model of human myeloma bone disease.
    Garrett IR; Dallas S; Radl J; Mundy GR
    Bone; 1997 Jun; 20(6):515-20. PubMed ID: 9177864
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current and Future PET Imaging for Multiple Myeloma.
    Ishibashi M; Takahashi M; Yamaya T; Imai Y
    Life (Basel); 2023 Aug; 13(8):. PubMed ID: 37629558
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An indium-111-labelled membrane-targeted peptide for cell tracking with radionuclide imaging.
    Pruller J; Pham TT; Blower JE; Charoenphun P; Volpe A; Sunassee K; Mullen GED; Blower PJ; Smith RAG; Ma MT
    RSC Chem Biol; 2023 Jan; 4(1):65-73. PubMed ID: 36685254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patient-Derived Multiple Myeloma 3D Models for Personalized Medicine-Are We There Yet?
    Lourenço D; Lopes R; Pestana C; Queirós AC; João C; Carneiro EA
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361677
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An Improved Animal Model of Multiple Myeloma Bone Disease.
    Mehdi SH; Morris CA; Lee JA; Yoon D
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503090
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting Notch Inhibitors to the Myeloma Bone Marrow Niche Decreases Tumor Growth and Bone Destruction without Gut Toxicity.
    Sabol HM; Ferrari AJ; Adhikari M; Amorim T; McAndrews K; Anderson J; Vigolo M; Lehal R; Cregor M; Khan S; Cuevas PL; Helms JA; Kurihara N; Srinivasan V; Ebetino FH; Boeckman RK; Roodman GD; Bellido T; Delgado-Calle J
    Cancer Res; 2021 Oct; 81(19):5102-5114. PubMed ID: 34348968
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Animal Models of Multiple Myeloma Bone Disease.
    Mehdi SH; Nafees S; Mehdi SJ; Morris CA; Mashouri L; Yoon D
    Front Genet; 2021; 12():640954. PubMed ID: 34163520
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Laboratory Mice - A Driving Force in Immunopathology and Immunotherapy Studies of Human Multiple Myeloma.
    Pisano M; Cheng Y; Sun F; Dhakal B; D'Souza A; Chhabra S; Knight JM; Rao S; Zhan F; Hari P; Janz S
    Front Immunol; 2021; 12():667054. PubMed ID: 34149703
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic Targeting of Protein Disulfide Isomerase PDIA1 in Multiple Myeloma.
    Hasipek M; Grabowski D; Guan Y; Alugubelli RR; Tiwari AD; Gu X; DeAvila GA; Silva AS; Meads MB; Parker Y; Lindner DJ; Saunthararajah Y; Shain KH; Maciejewski JP; Reu FJ; Phillips JG; Jha BK
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34071205
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Additive Benefits of Radium-223 Dichloride and Bortezomib Combination in a Systemic Multiple Myeloma Mouse Model.
    Suominen MI; Mäki-Jouppila J; Huhtinen A; Sjöholm B; Rissanen JP; Luostarinen A; Fagerlund KM; Alhoniemi E; Siemeister G; Mumberg D; Käkönen SM; Scholz A
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070363
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extramedullary multiple myeloma patient-derived orthotopic xenograft with a highly altered genome: combined molecular and therapeutic studies.
    Farre L; Sanz G; Ruiz-Xivillé N; Castro de Moura M; Martin-Tejera JF; Gonçalves-Ribeiro S; Martinez-Iniesta M; Calaf M; Luis Mosquera J; Martín-Subero JI; Granada I; Esteller M; Domingo-Domenech E; Climent F; Villanueva A; Sureda A
    Dis Model Mech; 2021 Jul; 14(7):. PubMed ID: 33988237
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current Understanding of Myelomatous Mesenchymal Stromal Cells Extended through Advances in Experimental Methods.
    Ichii M; Hosen N
    Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33374627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.